Absence of Adverse Change. Since the date of the Financials there has not been any material adverse change in the financial condition, business, assets, liabilities or results of operations of the Hospital.
Absence of Adverse Change. Since December 31, 1997 (and excluding any effects of the transactions contemplated hereby), Wang and its subsidiaries, taken as a whole, have not suffered any material adverse change in their business, assets, properties, liabilities, results of operations or condition (financial or otherwise).
Absence of Adverse Change. Purchaser shall not have suffered any material adverse change in its financial condition, business, property or assets since the date of this Agreement.
Absence of Adverse Change. Conduct of Drug Discovery Program. Since September 30, 1995, there has been no material adverse change in the Drug Discovery Program, the assets utilized therein, or the personnel conducting of such Drug Discovery Program, and there is no condition or development or contingency of any kind existing or in prospect which, so far as reasonably can be foreseen by PerSeptive, may result in any such material adverse change. Without limiting the foregoing, except as disclosed on Schedule 2.07, since September 30, 1995 there has not been, occurred or arisen: (i) any damage, destruction or loss to any Transferred Asset (whether or not covered by insurance) that, individually or in the aggregate, would have a material adverse effect on the Drug Discovery Program or prospects of the Drug Discovery Program; (ii) any general increase in any compensation or benefits payable to the Employees other than normal merit increases; or (iii) any commitment (contingent or otherwise) to do any of the foregoing.
Absence of Adverse Change. Since December 31, 1995, there has been no material adverse change in the business, financial condition, operations or assets of ChemGenics. Since December 31, 1995 ChemGenics has conducted its business in the ordinary course.
Absence of Adverse Change. There has not been, since the Sellers' Balance Sheet Date, any material adverse change in the business, assets or financial condition of IDP and PRIMO considered as one entity. To the knowledge of Sellers, there has been no occurrence, circumstance or combination thereof which might reasonably be expected to result in any such material adverse change.
Absence of Adverse Change. There has not been, since the Purchaser Balance Sheet Date any material adverse change in the business, assets, financial condition or prospects of the Purchaser. There has been no occurrence, circumstance or combination thereof which might reasonably be expected to result in any such material adverse change.
Absence of Adverse Change. Bethel represents that, since June 30, 2012, there has not been any material change in the financial condition, results of operations, assets, liabilities or business of the Water System, whether or not described in the financial statements described in Section 3.10 hereof, other than changes in the ordinary course of business, which have not been materially adverse.
Absence of Adverse Change. Since the date of the Seller Financial Statements delivered by Sellers to Purchaser, there has not been any material adverse change in the financial condition, business, assets, liabilities, results of operations or prospects of a Seller or of the Facilities, whether in the ordinary course of business or otherwise.
Absence of Adverse Change. Neither Olsy, Olsy Japan, Olsy Brazil and the Controlled Subsidiaries, taken as a whole, nor Olsy or any of the Major 139 148 Subsidiaries, taken separately, shall have suffered any material adverse change in their business, assets, properties, liabilities, results of operations or condition (financial or otherwise).
